Group Strategic Report FINANCIAL REVIEW NMC Health delivered a strong The Company was able to capitalise The company has spent a total amount performance in 2014 at both the Group certain expenses, in accordance with of US$3.2m as of 31 December 2014 on and divisional level.
Consolidated Group IFRS and the Companys accounting the Enterprise Resources Planning ERP Revenues increased from US$550.9m in policies.
We expect this to continue financial system and Hospital Information FY2013 to US$643.9m in FY2014, a growth in relation to costs for example lease System HIS.
After elimination of US$27.2m of costs arising during the construction of intra-group trading revenue, Consolidated future projects.
Although pre-operating The company has reviewed all significant Group EBITDA improved from US$92.9m expenses were nil in the year to capital expenditure projects including the in FY2013 to US$102.5m in FY2014, a growth 31 December 2014, we expect a small delayed projects for impairments and of 10.2%.
level of pre-operating costs which will have concluded that the projects have be expensed in the 2015 financial year as sufficient headroom and concluded that Group Net profit reached US$77.5m in a result of the opening of new facilities.
none of the assets are impaired.
FY2014, yielding Earnings per share EPS of US$0.412 compared to US$0.367 for the As a result of the delays in the opening CASH same period in 2013. of certain facilities discussed in Business Net cash inflow from operating activities overview, additional costs in respect for the 2014 financial year was US$85.7m, HEALTHCARE DIVISION of loan interest and leases have been compared with US$85.1m for the Revenue in the Healthcare division capitalised.
Had these facilities opened in comparative period in 2013.
This was increased from US$289.3m in FY2013 to line with original plan these costs would mainly due to the improved performance US$332.2m in FY2014, a growth of 14.8%.
Other than these of the Group and effective management EBITDA increased from US$81.7m in items the delays have not resulted in an of working capital, despite an increase FY2013 to US$88.2m in FY2014, a growth increase in budgeted capital costs.. in the revenues.
EBITDA margin declined from 28.2% in FY2013 to 26.6% in FY2014, as a A table outlining original estimated capital Including funds held on deposit, cash as result of the losses from the three new expenditure and other budgeted costs for at 31 December 2014 was at US$263.2m facilities opened during the year.
each of our current development projects compared to US$268.7m at the end of is set out in table below.
The company had allocated the DISTRIBUTION DIVISION funds raised through the IPO as well Within the Distribution division, revenues Apart from the projects mentioned in the as through the JP Morgan syndicated increased from US$300.2m in FY2013 to table below, the Group had spent US$9m loan against the capital cost of the five US$338.9m in FY2014, a growth of 12.9%.
on the acquisition of BR Medical Suites expansion projects announced during EBITDA increased from US$29.9m in during 2012 as part of the projects the IPO.
As a result, together with positive FY2013 to US$34.1m in FY2014, a growth announced during the IPO.
operating cashflow, the Company is well of 14.1%.
EBITDA margin was at 10.1% in financed to complete its capital FY2014 10.0% during FY2013.
In addition to the above, the Group expenditure program.
has spent US$7.7m from its internal CAPITAL EXPENDITURE funds towards the development of the Capital expenditure incurred for the year Al Ain Medical Centre which commenced was US$112.3m FY2013: US$82.7m.
This operations on 07 December 2014. encompassed US$96.0m on the Groups capital projects.
The Group also incurred US$13.5m on equipment required across the existing operations.
All US$m Budget Actuals Accounting Budgeted Capital Capitalised adjustment for Total 1 Project Capital Costs Costs Expenses lease rentals Capital Costs Brightpoint Royal Womens Hospital 70 75.8 6.1 25.5 107.4 Khalifa City Specialty Hospital 200 95.0 6.8 101.9 Day Surgery Centre LLC 15 10.4 1.1 2.8 14.3 Dubai Investment Park LLC 30 27.0 2.5 5.8 35.3 Total 315 208.2 16.5 34.1 258.9 Notes: 1: Prior to commencement of development of the existing four capital projects, management had an expectation that there would be an element of expense incurred before the new facilities were opened which would be written off through the Income Statement.
Following a review certain of these costs have been capitalised in line with the Companys accounting policies for example lease rent paid and finance costs.
The Group expects such costs will continue to be capitalised on these projects during the construction phase.
2: The lease in respect of Brightpoint contains a rent free period as well as specified rent increases.
In line with IFRS and the Companys accounting policies, the rental cost of the lease has been adjusted to appropriately account for these items over the length of the lease.
Accounting policies stipulate that the total lease value for the full lease period is divided evenly over the years.
24 NMC Health plc Annual Report 2014 Group Financial Overview Strategic Report Governance Statements As expected, the Group had a net debt timing of receipt of debtors and the FINANCE COSTS AND INCOME position of US$113.0m at 31 December timing of payment of creditors as well Total finance costs for 2014 were 2014 compared with US$63.7m at as inventory flow during the year and the US$14.4m compared to US$14.3m in 2013.
As the Group continues timing of re-imbursement of promotional This was mainly on account of the with its capital project development expenses agreed with our Principals savings from the JP Morgan facility which program, and the Companys cash is in relation to the sale and marketing of carried a relatively lower finance charge committed to such projects, the level their products.
The Distribution division as the LIBOR rate softened during the of net debt is expected to increase requires external working capital facilities year.
Apart from this the efficient during FY2015.
throughout the year, the level of which utilization of working capital lines also is dependent on business seasonality.
MOVEMENT IN NET DEBT These working capital facilities are The movement in cash and the level of arranged through a number of banking As part of the Groups capital expenditure capital expenditure have had a significant providers and in general terms the level programme, borrowing costs of US$4,068,000 effect on the movement in net debt of working capital required is between 2013: US$4,886,000 net of finance income during the 2014 financial year.
A summary 30%-40% of the Groups total debt facilities of US$NIL 2013: US$54,000 have been of the principal drivers is shown in the capitalised during the year.
The rate used table below.
LONG TERM DEBT FACILITIES to determine the amount of borrowing In 2013, the Group had raised a five year costs eligible for capitalisation was 3.15% WORKING CAPITAL debt facility of up to US$300m through 2013: 3.40% which is the effective rate of Working capital for our two operating a syndicate of lenders led by J. P. Morgan the borrowings used to finance the business divisions is funded differently Chase Bank, to refinance high interest capital expenditure.
due to the nature of their business bearing credit lines.
The Group is able to fund its has been drawn down from this facility DIVIDEND working capital requirements for its to date.
The cost of funds for this facility The Board is proposing to continue with Healthcare division from operational cash is 3.0% over one month LIBOR.
its policy of annual dividend payments flow, and we do not expect this position of between 20% and 30% of profit after tax, to change in the 2015 financial year.
The total debt of the Group, excluding outlined in the Companys IPO prospectus accounts payable and accruals, was in 2012.
The Board is therefore In relation to our Distribution division, the US$376.1m as at 31 December 2014 recommending that a final dividend of working capital requirement is dependent compared to US$332.4m as at 5.4 pence per share be paid in cash in on a number of factors including the 31 December 2013. respect of the year ended 31 December 2014 FY2013: 4.4 pence per share.
Movement of Net Debt amounts in US$m Total Debt as at 1 January 2014 332.4 Total Cash as at 1 January 2014 268.7 Net Debt as at 1 January 2014 63.7 Add: Add: Other Bank facilities & refinancing Net Movement 93.7 Operational cash inflow 85.7 Finance Income 3.6 Other Bank facilities & refinancing Net Movement 93.7 183.0 Less: Less: JP Morgan Loan Repayments 50.0 JPM Loan Repayments 50.0 Additions & Disposals to Property 111.2 Finance Costs 13.6 Dividends Paid 13.8 188.6 Total Debt as at 31 December 2014 376.1 Total Cash as at 31 December 2014 263.1 Net Debt as at 31 December 2014 113.0 NMC Health plc Annual Report 2014 25
